BLACK DIAMOND THERAPEUTICS I shareholders Q2 2023

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 75 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

BLACK DIAMOND THERAPEUTICS I shareholders Q2 2023
NameSharesValueWeighting ↓
Cutler Group LLC / CA 1,400$30.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 180,500$911,5250.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 43,900$221,6950.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 51,486$260,0040.00%
OSAIC HOLDINGS, INC. 2,484$11,7640.00%
NewEdge Advisors, LLC 17$860.00%
RHUMBLINE ADVISERS 449$2,2670.00%
TWO SIGMA ADVISERS, LP 12,800$64,6400.00%
SIMPLEX TRADING, LLC 350$10.00%
UBS Group AG 8,519$43,0210.00%
FEDERATED HERMES, INC. 5,046$25,4820.00%
VANGUARD GROUP INC 1,481,385$7,480,9940.00%
ROYAL BANK OF CANADA 1,355$7,0000.00%
AE Wealth Management LLC 15,920$80,3960.00%
BARCLAYS PLC 124,351$6280.00%
Tower Research Capital LLC (TRC) 2,116$10,6860.00%
Qube Research & Technologies Ltd 22,904$115,6650.00%
Beaird Harris Wealth Management, LLC 36$1820.00%
CWM, LLC 9$00.00%
BANK OF AMERICA CORP /DE/ 12$600.00%
External links

This page lists BLACK DIAMOND THERAPEUTICS I's shareholders in Q2 2023. To view BLACK DIAMOND THERAPEUTICS I's shareholder history, click here.